European Health Policy “Development Passport” for Greece

Excellent opportunities for strengthening the health sector, but also for the overall modernization of the country at the European level, arise from the new European health policy adopted on the occasion of the difficulties that arose from the recent coronavirus pandemic, but also from the next health sector. crisis expected internationally from unknown disease X when it appears.

The changes that are now starting at the European level have also contributed to the advancement of science and new technologies that introduce new innovative treatments, as well as the use of big data, which leads healthcare systems to changes that open up new areas of opportunity for our country. .

The Professor of Health Policy from the London School of Economics spoke about the favorable outlook that is emerging for Greece with regard to European health policy, but also to the international conditions that are taking shape.

Ilias Mosialos from the floor of the Panhellenic Conference on Health Economics and Policies, which this year is entitled “40 years of ESY – Collaborative solutions for a sustainability health system”.

Professor Mosialos was awarded this year with the “Yiannis Kyriopoulos” award, which is presented by the Conference for the first time.

In his lecture that followed, he highlighted the work and personality of the late Professor Kyriopoulos, among other things, pointing out that “if it weren’t for Giannis, nobody would be here”, stressing himself that “I wouldn’t have done what I did, if I hadn’t met Giannis. I owe him a big thank you.”

Referring to the upcoming changes in the EU regarding the health sector, he highlighted the constitutional asymmetry that exists between the member states and stressed that the state is coming to correct market failure, which is desirable for the health and education sectors because the market is not interested about the vulnerable.

Here, however, the state crosses ideological boundaries, the professor pointed out, citing as an example Germany, which has a much stronger welfare state, even than Sweden.

European health policy

Mr. Mosialos highlighted the strategic approach of the European Health Union and the creation of the Directorate-General for Health, HERA, stressing that the new structure has sufficient funds to overcome the possible next crisis caused by disease X, which we do not know when it will come.

Subscription model

But we already have antimicrobial resistance and industry is not willing to invest in making a drug that we won’t use but will have available when needed.

To this end, a “subscription model” is being studied in Sweden and Japan, as well as in other countries, where an amount will be provided to the pharmaceutical industry each year to make the medicine immediately available without being used. Other countries are also looking for smart forms of incentives for antibiotics.


During the pandemic, it was discovered that Europe no longer has raw material production and that most of it comes from China and India, which geopolitically raises the question of European sovereignty.

In terms of raw materials, billions are available and the Greek pharmaceutical industry can play a pioneering role in Europe.

Centers can also be established to track virus families and their mutations, as is the case with influenza.

Global health protection

With the new European policy for global health governance, we should also see the funding of centers at G20 level or jointly with some other rich countries. Someone has to bear the cost of global health protection. This is because follow-up research after basic research has the greatest cost.

Moreover, global protection cannot be achieved only by Europe. It needs cooperation with the US, Russia and China.

Like the World Health Organization, which would likely be disbanded if Trump were elected.

Despite the existence of the Organization, multi-splitting has been seen during the pandemic and therefore needs much attention.

The modernization of the European Center for Infection Control (ECDC) should lead to the creation of a pan-European center identified with the WHO Regional European Center for Communicable and Non-Communicable Diseases with the participation of Turkey, the Balkans, Armenia, Georgia, Moldova, Ukraine.

Big data

Speaking about the Health Data Space, Mr. Mosialos pointed out that 75% of Greeks’ health data is collected in IDIKA. The system should also be extended to the private sector, whether or not there is social security to provide the remaining 25% of data.

He noted that these numbers are real data and not products of clinical trials where the population is highly selected because comorbidities, outcomes in the treatment of the elderly, etc. are taken into account.

However, the problem in Greece is that IDIKA does not have the ability to process this data to create an appropriate health policy.

Moreover, we do not have a national biobank. The combination of data from IDIKA, the creation of a national biobank, data from the private health sector in combination with behavioral data from existing applications can bring important information for the formulation of health policy, significantly advancing the role of our country on an international scale.

“National disgrace”

Speaking about the role of the EOF and the central approval process, he clarified the fact that Greece is not a reference country, so a new medicinal product file cannot be submitted there and its approval gives registration throughout Europe. However, such an option would bring extremely important revenues to the EOF. And the country’s weakness on this point was described by Mr Mosialos as a “national disgrace”.

Artificial Intelligence

Regarding artificial intelligence and future changes, Mr. Mosialos noted that there should be a national committee because these are matters of national and European sovereignty. “If the Chinese or the Japanese dominate, we’ll paint it,” he said characteristically.

He compared the issue of artificial intelligence to nuclear weapons, saying that with nuclear it is easier because it involves interstate agreements, while with artificial intelligence not only states are involved in the problem, to emphasize that “here is dominant Apple, Google and now comes Amazon”.

Rishi Sunak

At this point he noticed that Greece was absent from the meeting called by the English Prime Minister on artificial intelligence, as it was not invited, and health, which provides 60% of the data, was not on the agenda.

In conclusion, Mr. Mosialos spoke about new technologies and a unified European evaluation in 2025 of gene and cell therapies, in 2028 of medicines for rare diseases and in 2030 of all medicines.

At this point, he saw the possibility of the country participating in joint management with the modernization of the EOF.

Leave a Reply

Your email address will not be published. Required fields are marked *